All News

Orchid Design Hires New Director of Engineering

Shelton, CT, July 28, 2017 –(PR.com)– Orchid Design (Orchid), a leader in innovative surgical device design, development and regulatory services for the orthopedic and spine industry, is pleased to announce the appointment of a new Director of Engineering for its Shelton, Connecticut design center. Poised for continued growth, Orchid has […]

Exactech Q2 Revenue $67.3 Million On Continuing Strong Extremities Revenue

July 27, 2017 GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, Inc. (Nasdaq:EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that revenue for the second quarter of 2017 increased 2% to $67.3 million from $66.1 million in the second quarter of 2016, […]

NuVasive Reports Second Quarter 2017 Financial Results

SAN DIEGO, July 27, 2017 /PRNewswire/ — NuVasive, Inc. (Nasdaq: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, announced today financial results for the quarter ended June 30, 2017. Second Quarter 2017 Highlights Revenue increased 10.3% to $260.6 million, or 10.7% on a constant currency basis; GAAP […]

NuVasive Announces New Organizational Structure To Drive Growth And Profitability Goals

SAN DIEGO, July 27, 2017 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), a leading medical device company focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced a new organizational structure to drive the Company’s growth and profitability goals, supporting its strategy to help deliver safer, more predictable spine surgery. “As the […]

Global Orthobiologics Market Forecast 2017-2025

LONDON, July 26, 2017 /PRNewswire/ — KEY FINDINGS The orthobiologics global market is anticipated to grow from $ 6596 million in 2016 to $ 12019 million by 2025. The market is expected to grow at a CACR of 6.97% between 2017-2027. The base year considered for the market study is 2016. The forecast period is 2017-2025. Evolvement […]

Camber Spine Technologies Announces Exceeding the 150th Implantation of ENZA™ Zero-Profile ALIF

WAYNE, Pa., July 27, 2017 /PRNewswire/ — Camber Spine Technologies, today announced that they have exceeded 150 implantations of the ENZA™ Zero-Profile ALIF device that was launched last July. “We have been doing anterior spine reconstructions for over 20 years and have used a lot of different ALIF devices,” said Orthopedic Surgeon, Dr. Steven […]

Zimmer Biomet Reports Second Quarter 2017 Financial Results

WARSAW, Ind., July 27, 2017 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended June 30, 2017.  The Company reported second quarter net sales of $1.954 billion, an increase of 1.1% over the prior year period, and an increase of 2.1% on a constant currency basis.  Excluding […]

4WEB Medical Announces First U.S. Surgeries with 3D Printed Lateral Spine Truss System

NEW YORK, July 27, 2017 /PRNewswire/ — 4WEB Medical, the industry leader in 3D printed implant technology, announced today the first surgeries utilizing the company’s Lateral Spine Truss System were recently performed in several notable hospitals in the United States. The company’s lateral interbody fusion device was designed to solve known surgical problems associated […]

Anika Announces Appointment of Joseph Darling as President

July 27, 2017 BEDFORD, Mass.–(BUSINESS WIRE)–Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company specializing in therapeutics based on its proprietary hyaluronic acid (“HA”) technology, today announced the appointment of Joseph Darling, an orthopedic and medical device veteran with broad commercial experience, to the role of President. For the past […]

Samumed Successfully Completed 52-Week Phase 2 Study for Treatment of Osteoarthritis of the Knee

July 27, 2017 SAN DIEGO–(BUSINESS WIRE)–Samumed, a leader in cartilage regeneration research, today announced the successful completion of a 52-week Phase II clinical trial of its potential treatment for osteoarthritis (“OA”) of the knee. SM04690 is a novel, small molecule inhibitor of the Wnt pathway, administered as an intra-articular injection. […]

© 2025 MedDeviceJobs.com | Powered by Careerleaf
v.4.6.7-9-gdb70438